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Introduction
Chromium(III) is an essential nutrient in humans, hav-
ing significance in sugar metabolism, immune processes, 
and neuroendocrine responses [1-4]. However, numerous 
studies have shown that chronic occupational exposure to 
chromium compounds and their uptake can cause deleteri-
ous long-term health effects to employees. The exposure 
to chromium due to chemical manufacturing of that ele-
ment can occur predominantly by inhalation or through 
skin contact with chromium-contaminated dust and aero-
sols usually containing particularly harmful hexavalent 
chromium (Cr(VI)) compounds (most often – chromate or 
dichromate). People working in such conditions – mainly 
workers in chrome plating industry, stainless steel manu-
facturing, and pigment production, especially those having 
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Abstract
Twenty-four male industrial workers, exposed to various chromium compounds for 1-17 years (but de-
prived of overt symptoms of chromium toxicity) were the subjects of our study. The workers’ urine chromium 
was measured serially by atomic absorption spectrometry. The simple kinetic model was proposed for track-
ing pre-shift and post-shift as well as day-to-day variation of urine chromium concentrations. This model 
proved to be useful in determining the biological effects of exposure to chromium compounds. subsequently, 
the statistically significant associations of chromium status parameters (as delivered by the kinetic model) 
with biochemical indices, blood panel parameters, spirometric indices, and concentrations of tumour mark-
ers [carcinoembryonic antigen (CEa), squamous cell carcinoma antigen (scc-Ag), cytokeratin 19 fragment 
(cyFrA 21-1), and neuron-specific enolase (nSE)] in those workers were evaluated by means of the hierar-
chical partial least squares method (Pls2 model). These relations should be further studied in larger groups of 
workers. in several individuals, outlined in the Pls2 model, cigarette smoking did not constitute any impor-
tant source of chromium, although seniority at work in the chemical plant did influence biochemical status.
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no proper outfit against ambient air (gloves, masks, pro-
tective clothing) – have been recognized as being at high 
risk of airway irritation and obstruction (bronchospasm, 
occupational asthma, nasal ulceration), allergic dermatitis 
and rhinitis as well as possibly lung cancer and other ma-
lignancies (e.g. prostate cancer, leukemia) [2, 5]. bagchi et 
al. demonstrated that a cascade of cellular events, including 
Dna damage, is responsible for chromium(VI)-induced 
toxicity and carcinogenesis [6]. in contrast, trivalent chro-
mium (Cr(III)), being the kinetically stable and not well 
soluble form, is poorly absorbed in the gastrointestinal tract 
and is generally assumed not to be toxic [7].
On the other hand, increased levels of tumour mark-
ers: carcinoembryonic antigen (CEa), squamous cell 
carcinoma antigen (scc-Ag), cytokeratin 19 fragment 
(cyFrA 21-1), and neuron-specific enolase (nse) may 
indicate the onset of the carcinogenic process. Moreover, 
elevated concentrations of these tumor markers are gen-
erally accepted to be unfavourable prognostic factors in 
lung cancer patients [8, 9].
little information is available on possible relations 
between exposure to chromium compounds, tumour 
markers, and spirometric indices, as well as hematologi-
cal and biochemical parameters in workers exposed to oc-
cupational doses of that metal. Therefore, the objectives 
of the current study were:
 1) to formulate an adequate kinetic model of chromium 
intake and excretion;
 2) to reveal the correlation structure of data by multivari-
ate analysis (Pls2 model);
 3) to check the importance of cigarette smoking and/or 
demographic parameters as potential sources of chro-
mium in the individuals outlined in the Pls2 model. 
Experimental
Subjects and Materials
The subjects of investigation were twenty-four male 
industrial workers of a small chemical plant, aged 23-53 
years (mean 36.7), exposed continuously for 1-17 years 
(mean 7.2) to various chromium compounds at different 
concentrations, depending on the workplace. With only 
one exception, the subjects had no clinical or radiologi-
cal symptoms of lung diseases. all of them were free of 
any acute disease. They underwent routine prophylactic 
examinations at the małopolski center for occupational 
Medicine. Each subject gave his informed consent to par-
ticipate in the study and was asked to provide information 
on height, weight, smoking habits, and medical history.
For the duration of the subjects’ exposure, the chemi-
cal plant produced chrome oxides and chromate-pigments, 
including chromium(iii) oxide, chromium(Vi) oxide, 
chromium(VI) sulfate basic, sodium dichromate(VI), and 
potassium dichromate(VI). The concentration of chromate 
dust in the subjects’ work environment ranged from 0.010 
to 0.096 mg/m3 (geometric means for different days: 0.011 
– 0.080 mg/m3), while the concentration of chromium(III) 
oxide was in the range of 0.008 to 0.100 mg/m3 (geometric 
means for different days: 0.009-0.080 mg/m3).
The concentration of chromium in urine was used as 
a biomarker of occupational exposure to this metal [10]. 
urine samples were collected serially, within a ca. two-
week period, before and after a work shift, into plastic 
cups which had previously been washed with 5% Hno3. 
To avoid contamination with dust during sample collec-
tion, specimens were collected outside the working area 
and subjects were asked to wash hands. The urine samples 
were divided into two aliquots: the first was used for cre-
atinine analysis, the second was spiked with conc. nitric 
acid to obtain 1% v/v final acid concentration and kept in 
refrigerator until the analysis.
blood samples were taken from the cubital vein: one 
part (on anticoagulant) was used to determine the hemato-
logic parameters and another was used for the biochemi-
cal examination. Hemoglobin and blood cell count were 
assessed using the hematological analyzer cell Dyn 3700. 
serum was separated 30 min after collection, transferred 
with a pipette to four polypropylene Eppendorf tubes and 
then frozen.
Analytical Methods
Spectrometric measurements of electrothermal atomic 
absorption of urine chromium concentrations were per-
formed on the Perkin elmer® model 5100 zl with lon-
gitudinal zeeman-effect background correction equipped 
with an As-70 automatic sampler and a chromium hol-
low cathode lamp (norwalk, CT, uSa). Purge gas argon, 
active gas air, and pyrolytically coated graphite tubes 
with stabilized temperature platform furnace were used 
throughout. absorption readings, measured as peak area, 
were determined at the wavelength of 357.9 nm and at the 
slit width of 0.7 nm. The detection limit was 1.1 µg/l, 
precision was 8.5%, and the calibration range was 0-250 
µg/l. An internal quality control procedure was used to 
validate the analytical method. Seronorm reference urine 
enriched with toxic elements was purchased to assess ac-
curacy of cr measurements (batch no. 403125, nycomed 
Pharma As, oslo, norway). The mean analyzed value 
was 21.1±1.8µg/l (certitified value 20.0µg/l).
The serum total proteins concentration was deter-
mined by the biuret method, and the levels of electropho-
retical fractions (α1-globulin, α2-globulin, β-globulin, 
γ-globulin) were calculated on the basis of densitometry 
of electrophoregrams, after separating proteins in agarose 
gel. CEa and SCC-ag were determined by micropar-
ticle enzyme immunoassays (meiA method) using the 
Abbott laboratories kit and Axsym and imx systems, 
respectively. cyFrA 21-1 and nse were measured by 
an electrochemiluminescence immunoassay (EClIa) 
method with materials from Roche Diagnostics and using 
the roche elecsys 2010 analyzer. spirometric parameters 
(forced vital capacity, FVc; forced expiratory volume in 
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1s, FeV1; middle expiratory flow 75% FVc, meF75) were 
obtained from flow-volume curves and the computer-
aided system (lungtest MES, Poland). blood was taken 
for all analyses, and the respiratory examination was per-
formed when the workers had their day off.
Statistical Approach
having several clusters of predictor parameters which 
constituted the groups of potential diagnostic factors (chro-
mium status parameters, spirometric indices, clinical param-
eters and some other biochemical parameters) and several 
response parameters (tumour markers), we employed the 
hierarchical partial least squares regression method (Pls2) 
to establish data structure as well as a possible causal rela-
tionship between dependent variables and potential explan-
atory variables which are contained in the blocks of data. 
The Pls2 method is a well-known multivariate pattern re-
cognition method, whose algorithm is based on the disjoint 
principal component model. Pls2 finds the numerical so-
lution by means of correct, reduced dimensionality of the 
original data. It is also worth noting that the assumption of 
the postulated distribution of data is not necessary in Pls2. 
The Pls2 algorithm in various applications has been de-
scribed in many papers [11, 12]. For the Pls2 analysis all 
parameters were scaled to unit variance. The Pls2 model 
was validated by full cross-validation. The plots of the Pls2 
score vectors were used to identify outlying subjects. Sta-
tistical computations were carried out using the commer-
cially available packages: simcA-P v.9 (umetrics, umea, 
sweden), sTATisTicA Pl v.6 (statsoft, Tulsa, usA), and 
Statgraphics (Manugistics, Rockville, uSa).
Results
The typical course of changes in chromium concentra-
tion in urine (ucr) is presented in Fig. 1. The data on chro-
mium concentration allowed us to formulate the simplified 
kinetic model of chromium absorption and excretion with 
the zero- and 1st-order rate constant, respectively. The de-
tails of the model are provided in Appendix 1. main de-
scriptive statistics of uCr, and of kinetic model parameters 
are shown in Table 1. Table 2 summarizes main descriptive 
characteristics of the blood panel, spirometric and smok-
ing parameters in the subjects, while Table 3 shows main 
descriptive statistics of biochemical parameters and tumour 
markers in the study. Mean values of the blood panel and 
biochemical parameters were always within respective 
normal ranges (only in 3 subjects were Hct values slight-
ly beyond the upper limit (49), being in the range 50-51). 
Similarly, spirometric parameters (fEV1, fVC and MEf75) 
were decreased in 3, 2 and 1 subject, respectively. with the 
exception of nse, all other tumour markers exceeded the 
upper limits of normal ranges in several individuals.
The statistically significant hierarchical Pls2 model 
with two significant components was derived. The ei-
genvalues were: 3.89 and 1.02. The first two components 
accounted for 98.2% and 86.1% of the variance in the 
predictor and response parameters, respectively. The pre-
dictor parameters included in this model were:
Table 1. main descriptive statistics of chromium concentration in urine (ucr), and of kinetic model parameters: mean half-life time of 
Cr elimination (t1/2cr), residual urine cr concentration (rcr0), mean integral cr elimination per workday (intcr), exposure-elimination 
zero-order rate constant (k0i) (see Appendix for explanation).
Parameter unit Median Quartile range Range
uCr µg cr/g creatinine 17.9 12.9-27.5 1.3-61.2*
t1/2Cr hour 10.0 9.6-20.1 4.5-33.4
rcr0 µg cr/g creatinine 6.0 4.9-11.3 1.0-36.4
intCr µg cr/g creatinine/workday 668 500-1291 253-4357
intcr normalized to 1 work-hour µg cr/g creatinine/hour 95.0 68.0-206.8 38.7-726.2
k0i µg cr/workday 2.52 2.1-6.1 0.06-19.0
k0i normalized to 1 work-hour µg cr/hour 0.41 0.28-0.91 0.01-3.17
* the reference value for urine cr, determined in our laboratory in healthy adults, was 1.18±0.77 µg cr/g creatinine.
Fig. 1. Typical course of changes in chromium concentration in 
urine (for symbol meanings see Appendix).
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 1) chromium status parameters: mean chromium concen-
tration in urine (after rejecting outlying values), me-
dian chromium concentration in urine after one work-
day, mean half-life time of chromium elimination via 
urine, mean integral Cr elimination per workday, re-
sidual urine cr concentration (see Fig. 1 and Appen-
dix); the latent variable calculated for this group of 
parameters is referred as ‘Cr status.’
 2) biochemical indices: concentrations of total serum 
proteins, albumin, α1-globulin, α2-globulin, β-globu-
lin, γ-globulin; the latent variable calculated for this 
group of parameters is referred to as ‘proteins.’
 3) blood panel: bsr, Hct, rbc, wbc, PlT; the two la-
tent variables calculated for this group of parameters 
are referred to as ‘bp’ and ‘bp(bSR),’ respectively. The 
variable ‘bp’ is mainly loaded by hct, RbC, WbC, 
PlT, while the variable ‘bp(bSR)’ is almost solely 
loaded by bSR.
 4) spirometric indices and smoking status: fVC, fEV1, 
MEf75, number of cigarettes smoked per day, age 
when subject commenced smoking; the latent variable 
calculated for this group of parameters is referred to as 
‘Spirometry.’
The response parameters included in the model were: 
ceA, scc-Ag, cyFrA 21-1, nse (tumour markers). 
The parameters of age, bMI, and k0i (exposure zero-or-
Table 2. main descriptive statistics of blood panel parameters (red blood cells – rbc, white blood cell – wbc, platelets – PlT, he-
matocrit – Hct, blood sedimentation rate – bsr), spirometric parameters (forced vital capacity – FVc, forced expiratory volume in 
1s – FeV1, middle expiratory flow 75% FVc – meF75), and smoking parameters (age of smoking commencement – aSC, number of 
cigarettes smoked per day – nCSD).
Parameter unit Mean Min max normal range [13, 14]
RbC cells /l 4.8 4.2 x 1012 5.4 x 1012 4.3 – 5.7 x 1012
WbC cells/l 6.9 5.1 x 109 9.2 x 109 4.5 – 11.0 x 109
PlT cells/l 201 x 109 152 x 109 295 x 109 150 – 450 x 109
hct % 45 40 51 39-49
bSR mm/h 4.6 1.0 13.0 0-15 
fVC % n 97.6 64.7 113 ≥ 80
fEV1 % n 95.8 58.9 118 ≥ 80
MEf75 % n 99.3 39.5 172 ≥ 60
aSC yr 23 17 46 -
nCSD cigarette/day 13 0 30 -
Table 3. main descriptive statistics of biochemical parameters (TsP - total serum proteins, α1-globulin, α2-globulin, β-globulin, γ-
globulin, albumin, lDh) and markers of carcinogenic effects (CEa -carcinoembryonic antigen, SCC-ag - squamous cell carcinoma 
antigen, cyFrA 21-1 - cytokeratin 19 fragment, nse - neuron-specific enolase).
Parameter unit Median Min max normal range [13, 9]
TSP g/l 76.3 71.3 83.8 64.0 – 83.0
albumin g/l 46.2 38.9 50.7 35 - 50
α1-globulin g/l 3.2 2.8 4.2 1 - 3
α2-globulin g/l 6.2 5.2 8.8 6 - 10
β-globulin g/l 9.2 7.4 12.0 7 -11
γ-globulin g/l 11.9 6.8 17.0 8 -16
CEa µg/l 1.3 0.1 8.0 0.0 – 7.1
SCC-ag µg/l 1.2 0.6 2.4 0.3 – 2.1
nSE µg/l 8.8 7.2 14.5 4.8 – 25.4
cyFrA 21-1 µg/l 1.6 0.6 3.3 0.2 – 3.0
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der rate constant) were omitted from this model as unin-
formative. The final plot, which comprised the weights 
(denoted as w*) that combined the predictor parameters 
with latent components, and the weights (denoted as c) 
that combined response parameters with latent compo-
nents, showed that bp(bSR) and CEa were interrelated, 
while three other tumour markers were influenced by 
all the remaining parameters (Fig. 2). The plots show-
ing the values predicted by the Pls2 model versus the 
observed ones for all response parameters enabled us to 
find the outlying subjects, i.e. those which were most 
distant from the regression curve. For example, Fig. 3 
illustrates such a plot for cyFrA 21-1 where two points 
were regarded as outliers. Generally, of the 24 subjects, 
7 were identified as outliers. The characteristics of these 
outlying subjects are listed in Table 4. The outlying sub-
jects differ from the rest of the study group in respect 
to seniority at work, but neither in the age they started 
smoking nor in the number of cigarettes they smoke per 
day (Table 5, Fig. 4).
Table 4. The clinical and demographic parameters data in 7 outlying subjects.
Subject
number
Parameter for which subject 
is outlying
age of smoking commence-
ment /current age (yr)
number of cigarettes 
smoked per day
Seniority at work in the 
chemical plant (yr)
1 ceA, cyFrA 21-1 20/40 10 17
2 CEa 20/36 20 9
3 SCC-ag 21/40 10 9
4 SCC-ag 19/44 20 13
5 cyFrA 21-1 19/30 15 12
6 nSE 17/23 15 4
7 nSE 22/53 15 17
Fig. 2. The weights of the first two components of the Pls2 
model (w*c1, w*c2). The meaning of labels: 1 – bp(bsr), 
2 – bp, 3 – proteins, 4 – spirometry, 5 – cr status, 6 – ceA, 
7 – cyFrA 21-1, 8 – nse, 9 – scc-Ag.
fig. 4. Seniority at work in a chemical plant in seven outliers 
and in the rest of the study group (0 – rest of the study group, 
1 – group of seven outliers).
Fig. 3. The values predicted by the Pls2 model versus the ob-
served ones for the cyFrA 21-1 parameter. The outlying sub-
jects were denoted as 1 and 5, and their characteristics are pro-
vided in Table 4.
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Discussion of Results
Caution is needed when interpreting the results of this 
relatively small study. nevertheless, the results showing 
the increase in chromium excretion during the workday 
are in reasonable agreement with results of other studies 
[15, 16]. The data provided by the current study show that 
large amounts of absorbed chromium were excreted into 
urine on exposure day, within several hours after expo-
sure (Fig. 1). This finding, and the high degree of varia-
tion in urinary chromium among subjects, are also in con-
cordance with the results reported by other authors, who 
– however – did not formulate any model of chromium 
absorption and excretion [5].
The experimental points and the calculated curve 
shown in Fig. 1 support the view that the proposed simple 
kinetic model provides an adequate fit to data on chromi-
um absorption and excretion via urine in the study group, 
and it is useful in determining the biological effect of ex-
posure to chromium compounds. It is worth stressing that 
the type of fitted curve was identical for all individuals, 
but particular parameters of the kinetic model were differ-
ent for each of them, as shown in the Appendix.
The values of tumour markers higher than the upper 
limits of normal ranges may reflect the potential risk of 
some disturbances due to chronic exposure to harmful 
chromium components – without any acute symptoms 
of toxicity at the time of examination. However, the 
above-mentioned parameters were within normal ranges 
for almost all subjects.
The Pls2 model confirmed the link between bio-
chemical indices, blood panel parameters, spirometric pa-
rameters, and the concentrations of tumour markers – in 
absence of overt signs of chromium toxicity. no systemic 
investigation of such dependency has been published so 
far. This link could have been even stronger if the ambi-
ent air had contained only Cr(VI) salts, which are readily 
absorbed through inhalation and are classified as potent 
carcinogens in humans. however, the air in the chemical 
plant included the mixture of different forms of chromium 
with diverse solubilities. It is also worth bearing in mind 
that inhaled hexavalent chromium is converted to trivalent 
chromium by the acidic environment in the stomach and 
in some parts of the respiratory tract, such as epithelial 
lining fluid, pulmonary alveolar macrophage or periph-
eral lung parenchyma cells. These incompletely defined 
defence mechanisms reduce the health risk [5, 7]
For people not occupationally exposed to chromium, 
cigarette smoking might constitute an important source 
of chromium intake and heighten the risk of lung cancer. 
In the individuals working in an atmosphere containing 
compounds of this metal, cigarette smoking (as declared 
by most of the subjects in our study) does not seem to 
constitute a source of chromium comparable to occupa-
tional exposure doses. in our study the subjects outlying 
in the Pls2 model differ from the rest only in respect to 
seniority at work. It is even debatable if cigarette smoke 
can react synergistically in strengthening chromium’s car-
cinogenic effects and promoting tumour growth [17].
In conclusion, our study points to the necessity of 
using the proper kinetic model in evaluating chromium 
status of workers occupationally exposed to chromium 
compounds. The revealed association between chromium 
status parameters (as delivered by the kinetic model), bio-
chemical indices, blood panel parameters, spirometric in-
dices, and the concentrations of tumour markers should be 
further studied in larger groups of workers.
It is worth adding that the same chemical plant from which 
the subjects of our study have originated has produced hazard-
ous waste dumped in the vicinity. It contains a large amounts of 
chromium and causes detrimental changes in the environment 
as was proved recently by means of specific biological indica-
tors of soil contamination. Thus, further monitoring of health 
status of chemical plant workers can be helpful in assessing a 
potential risk for the neighbouring human population.
Appendix
kinetic model construction of Cr elimination via 
urine:
k0i k1i fast route
→ absorption →
k1r long term path
exposure elimination
k0i –  exposure: zero-order rate constant
k1i –  elimination: fast route 1-st order rate constant, 
initially estimated from Cr concentrations as: – ln(uCr1 / 
uCr2) / tw
where: i – individual workday number
uCr1 and uCr2 – urine cr concentration (µg/g 
creatinine) after one workday and before the 
next one, respectively (see Fig. 1)
Table 5. comparison of demographic parameters for seven outlying subjects and for the rest of the study group.
Parameter   Outliers    Rest of the study group   
Mean Min max Mean Min max p
age of smoking commencement 19.7 17.0 22.0 24.4 17 46 0.2434
number of cigarettes smoked per day 15.0 10.0 20.0 11.9 0 30 0.2291
Seniority at work in the chemical plant 11.6 4.0 17.0 5.4 1.0 13.0 0.0066
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tw = 6 or 8 hours (workday period)
k1r –  elimination: long-term 1-st order rate constant
Constituents of kinetic model:
 1) exposure-elimination component (0-order rate of ex-
posure, 1-st order rate of elimination):
EX(ti)=(k0i / k1i) * (1-exp(-k1i * ti))
2) elimination-after-exposure component:
El(ti)= EX(tw) * exp(-k1i * ti)
3) residual long-term component of elimination:
rcr = rcr0 * exp(-k1r * t)
where: ti – work time count from 1-st hour of the moni-
tored workday; 
ti  <0; tw>
rcr0 – residual (background) urine cr concentra-
tion (see Figure 1)
t – internal time count (in hours from 1-st day of 
monitoring); t ∈ <0; 400 hours>
Total kinetics equation for Cr elimination:
ecr = ∑i
n
 [EX(t i) + El(t i)] + rCr
where: n – number of workdays monitored
The parameters: k0i, k1i, k1r, and rcr0 were fitted by 
means of the least-square method of minimization using 
the equation: y = ∑ i
n
 [ eCr – uCr ]
2 (sum of squared de-
viations of the model’s calculated values (eCr) from ob-
served data (uCr)).
for each subject the following parameters were de-
rived:
 1) t1/2Cr – half-life time of Cr elimination;  
t1/2cr = ln(2) / k1i
 2) rcr0 – residual urine cr concentration





where: j – subsequent time count (in hours) from the be-
ginning of monitoring.
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